IGF-1 DES

Volume: 4 ML

Dosage: 1 MG/VIAL

Clinical dosing: 10 - 300 mcg/day

Description:

Protein DES(1-3) IGF-1 is a truncated version of peptide hormone IGF-1 (insulin-like growth factor 1) in which the tripeptide Gly-Pro-Glu is absent from the N-terminus end of the protein. In other words, DES(1-3) IGF-1 lacks the first 3 amino acids at the N-terminus of insulin-like growth factor 1, and consists from total of 67 amino acids, relative to the 70 amino acids of IGF-1. It is naturally occurring endogenous hormone in human and mammals, that has been found in the human brain, cow colostrum, and pig uterine tissue. The amino acid sequence of DES(1-3) IGF-1 is TLCGAELVDA LQFVCGDRGF YFNKPTGYGS SSRRAPQTGI VDECCFRSCD LRRLEMYCAP LKPAKSA. Clinical opportunities for DES(1-3) IGF-1 have not yet been very evaluated, but could apply in catabolic states (using the peptide to induce anabolism in catabolic conditions such as muscular dystrophy) as well as for the treatment of inflammatory bowel diseases. IGF-1 has a strong ability to maintain and build muscle, especially DES(1-3) IGF-1 form. In addition to a direct anabolic effect on skeletal muscle, the production of more IGF-I is also capable of stimulating the proliferation and differentiation of muscle stem cells (satellite cells) – real growth of new muscle cells, and IGF-1 is the only hormone that can do this. DES(1-3) IGF-1 is also promising candidate for treat of a number of neurological diseases.

Compound Specifications:

Originale product made in UK.